Dr. Oleh Taratula, an associate professor of Nanotherapeutics in the Department of Pharmaceutical Sciences based on our Portland campus, received a 5-year, $2.3 million R01 grant from the National Cancer Institute, National Institutes of Health. Dr. Taratula’s project, “Novel Nanomedicine-Based Therapeutic Approach For Treatment of Cancer Cachexia,” is to develop a treatment for the weight loss […]
Author: millerga
Epidermal Lipids: Key Mediators of Atopic Dermatitis Pathogenesis. Trends Mol Med. 2019 May 1. pii: S1471-4914(19)30070-X. doi: 10.1016/j.molmed.2019.04.001. Bhattacharya N1, Sato WJ1, Kelly A1, Ganguli-Indra G2, Indra AK3.
Dr. Jon (JJ) Furuno, associate professor and interim chair of the Department of Pharmacy Practice, is the PI of a new 3-year, $1.5 million R01 award from the Agency for Healthcare Research and Quality (AHRQ) to develop an intervention bundle to improve antibiotic prescribing on discharge from hospital to long-term care facilities. This study includes […]
Drs. Jane Ishmael and Kerry McPhail, Associate Professors of Pharmacology and Medicinal Chemistry/Natural Products, respectively, in the Department of Pharmaceutical Sciences, received NIH R01 funding for $1.6 million to pursue natural products drug discovery research for a project titled “Modulation of Protein Biogenesis and Secretion by Natural Product Translocon Ligands.” Drs. Ishmael and McPhail are […]
Dr. Gaurav Sahay, an assistant professor of Drug Delivery and Nanotherapeutics in the Department of Pharmaceutical Sciences based on our Portland campus, received a 5-year, $3.3 million R01 grant from National Institutes of Health. Sahay’s project, “Nanoparticle-based mRNA delivery for treatment of cystic fibrosis,” is to develop a novel, inhalable system capable of delivering mRNA […]